Auto-injectors are these spring-loaded syringes, designed to deliver a single dose of a drug. These injectors are intended for easy to use and self –administration by patients, or untrained caregiver as well. Auto-injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
The global auto-injectors market is growing rapidly over the past few years mainly due to the burgeoning healthcare sector. Moreover, the factors such as the increasing prevalence of chronic diseases, allergy treatments, and anaphylaxis, worldwide, are escalating the market on the furthered height on the global platform.
In auto-injectors, the needle tip is shielded prior to injection. The depth of injection can be adjusted with a passive safety mechanism that also prevents accidental injection. At the touch of a button, these injectors automatically insert the needle and contents of the syringe into the skin without letting the user see the needle. Auto-injectors not only allow the automatic injection of a syringe but also have a visual indication that confirms the deliverance of the full dose, hence, these are preferred over the traditional syringes involved in the needle-based drug delivery devices. Affirmations stating that the auto-injectors are entirely safe and reliable for the self-administration of drug delivery are driving the growth of the market.
Get Free Sample Copy of “Auto-Injectors Market” @ https://www.marketresearchfuture.com/sample_request/2046
Moreover, the Increasing development and use of biological drugs (biologicals) & vaccines are expected to increase the market size from 2017 to 2022. Besides, factors such as the rising need for targeted and sustained drug delivery in the treatment of chronic diseases and the need for cost-efficient delivery of high-priced medications are fostering the growth of the market.
Additional factors propelling market growth include the rising prevalence of chronic diseases and the augmented demand for intensive care for patients in critical conditions. Moreover, the proliferation of home healthcare-based medical devices that are embedded with sensors is supporting the market allowing patients to self-administer the doses. These advantages are fostering the growth of auto-injectors market to a great deal. Furthermore, the increasing geriatric populace and rapidly changing lifestyle propel the growth of the market.
Established players are adopting strategic initiatives such as merger and acquisition of relatively small but promising companies in the Asia Pacific region to expand their business and to meet the increased demand for auto-injectors. They are majorly focused on increasing their supply to established facilities that have the high demand for the product.
Auto-injectors are made of glass syringes usually which makes them fragile and a probable cause of contamination. Currently, market players are striving to create auto-injectors syringes with plastic to prevent unnecessary contamination. Increased focus on the development of user-friendly and patient compliant devices is an upward trend among the industry players that the auto-injectors market is witnessing currently.
Some of the leaders in the market are
- Scandinavian Health Ltd,
- Unilife Corporation,
- Owen Mumford Ltd. (UK),
- Amedra Pharmaceuticals LLC,
- Kaleo, Inc.,
August 16, 2018 –– Teva Pharmaceuticals (Israel) announced receiving the FDA approval for its first generic epinephrine auto-injector made for the emergency treatment of allergic reactions, including anaphylaxis.
The approved product strengths generic versions of EpiPen and EpiPen Jr, is indicated for the use in adults as well as pediatric patients who weigh more than 33 pounds.
MRFR has segmented the report into four key dynamics for an easy grasp;
By Product Type: Disposable and Reusable among others.
By Application: Anaphylaxis, Allergies, Multiple Sclerosis, and Rheumatoid Arthritis among others.
By Suppliers: Online Retailers, Pharmacy, and Retailers among others.
By Regions: Europe, North America, Asia Pacific, and Rest-of-the-World.
Get More Professional and Technical Industry Insights @ https://www.marketresearchfuture.com/reports/auto-injector-market-2046
The North American region accounts for the dominating market for the auto-injectors. Factors substantiating the growth of the market in the region include technological advancements and the wide uptake of technologies in the medical sector. Substantial investments in the R&D activities for the development of new injectors and the extensive uses of sensor technology in drug delivery, drive the market growth.
Owing to the factors such as high healthcare expenditures and the increasing government funding for research the auto-injectors market in North America is expected to reach USD 0.9 BN by the end of 2022.
The European region is estimated to qualify as the second-largest market for auto-injectors. Factors such as the availability of well-established healthcare infrastructure, advanced treatment facilities, and the growing demand for quality healthcare propel the market in the region. Furthermore, the growth of biologics and the emergence of biosimilars in the burgeoning pharma markets in the U.S. and Europe is a key growth driver for the growth of the auto-injectors market.
Whereas, the Asia Pacific auto-injectors market is proliferating, emerging as one of the promising markets, globally. The rising healthcare expenditure and the increase in the number of pharma companies led by the improving economic conditions are propelling the market growth in the APAC region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312